multiple myeloma stories: relapsed/refractory mm patient shares daratumumab, elotuzimab experience
Published 3 years ago • 4.6K plays • Length 45:38Download video MP4
Download video MP3
Similar videos
-
19:02
multiple myeloma: newest treatments for relapsed/refractory mm | for patients & caregivers
-
1:03:36
latest cancer treatments in relapsed/refractory multiple myeloma | ask the md | the patient story
-
12:21
elotuzumab and daratumumab in multiple myeloma
-
10:16
daratumumab safe in relapsed/refractory multiple myeloma patients
-
33:19
how multiple myeloma treatment is changing and better for myeloma patients (relapsed/refractory)
-
46:01
clinical trials for multiple myeloma patients (selinexor, car t cell) | donna’s story
-
18:52
living life with myeloma | beth's multiple myeloma patient story (5 of 5) | the patient story
-
5:00
subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma
-
28:23
multiple myeloma: latest treatments | dr. nina shah, ucsf | the patient story
-
31:15
multiple myeloma in 2023: what patients & caregivers need to know now! | the patient story
-
47:35
top doctor & patient talk game changing cancer treatments: how close is a cure? (multiple myeloma)
-
12:21
moas for elotuzumab and daratumumab in multiple myeloma
-
2:19
update on eloquent-2: phase 3 trial of elotuzumab in relapsed/refractory multiple myeloma
-
1:07:49
watch the experts discuss the latest multiple myeloma updates: https://bit.ly/3swv3qu
-
4:03
imf ceo yelak biru shares his myeloma patient story
-
6:12
ash 2018: using daratumumab early with standard myeloma combos for newly diagnosed patients
-
2:47
talquetamab daratumumab is well tolerated in relapsed/refractory multiple myeloma patients
-
11:11
rationale for selinexor treatment in daratumumab-refractory multiple myeloma patients
-
3:27
case study: daratumumab in a relapsed patient